Stocks and Investing
Stocks and Investing
Mon, June 16, 2014
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, June 13, 2014
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, June 12, 2014
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, June 11, 2014
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, June 10, 2014
[ 12:00 AM ] - United States, WOPRAI
Chris Schott Maintained (TEVA) at Hold with Increased Target to $56 on, Jun 10th, 2014
Chris Schott of JP Morgan, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Increased Target from $55 to $56 on, Jun 10th, 2014.
Chris has made no other calls on TEVA in the last 4 months.
There are 3 other peers that have a rating on TEVA. Out of the 3 peers that are also analyzing TEVA, 1 agrees with Chris's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Risinger of "Morgan Stanley" Upgraded from Sell to Hold and Held Target at $52 on, Friday, March 14th, 2014
These are the ratings of the 2 analyists that currently disagree with Chris
- Liav Abraham of "Citigroup" Maintained at Strong Buy with Increased Target to $70 on, Tuesday, April 1st, 2014
- Ami Fadia of "Leerink Swann" Upgraded from Hold to Buy on, Thursday, March 6th, 2014
Contributing Sources